324767-92-2 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 5-hydroxy-3,6-dihydro-2H-pyran-4-carboxylate is used as an intermediate in the synthesis of various pharmaceutical drugs for its unique furan ring structure and reactivity.
Used in Chemical Synthesis:
Ethyl 5-hydroxy-3,6-dihydro-2H-pyran-4-carboxylate is used as a building block in the creation of other chemical compounds, contributing to the development of new materials and products in the chemical industry.
It is important to handle and store ethyl 5-hydroxy-3,6-dihydro-2H-pyran-4-carboxylate with care, as it may pose certain threats or hazards if not used properly, including potential environmental harm.
Check Digit Verification of cas no
The CAS Registry Mumber 324767-92-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,4,7,6 and 7 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 324767-92:
(8*3)+(7*2)+(6*4)+(5*7)+(4*6)+(3*7)+(2*9)+(1*2)=162
162 % 10 = 2
So 324767-92-2 is a valid CAS Registry Number.
324767-92-2Relevant articles and documents
OXOPIPERIDINYL AND PYRANYL SULFONAMIDES AS AMPA POTENTIATORS
-
Page/Page column 40, (2010/04/27)
The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of Formula (I) : as defined in the specification. The invention is also directed to compositions containing the compo
SULFONAMIDES AND PHARMACEUTICAL COMPOSITIONS THEREOF
-
, (2008/12/04)
The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula (I), as defined in the specification. The invention is also directed to compositions containing the compounds of formula (I).
COMBINATION DRUGS
-
, (2008/06/13)
The present invention relates to a pharmaceutical agent containing an anti-sepsis drug (e.g., cycloalkene compound), and at least one kind of drug selected from the group consisting of an antibacterial agent, an antifungal agent, a non-steroidal antiinflammatory drug, a steroid and an anticoagulant in combination.